Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis

BACKGROUND: This paper reports a systematic review and meta-analysis of all randomized controlled trials comparing the efficacy of lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in human epidermal growth factor receptor 2-overexpressing (HER-2+) locally advanced or metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Botrel, Tobias Engel Ayer, Paladini, Luciano, Clark, Otávio Augusto C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793631/
https://www.ncbi.nlm.nih.gov/pubmed/24115917
http://dx.doi.org/10.2147/CE.S50474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793631/
https://www.ncbi.nlm.nih.gov/pubmed/24115917
http://dx.doi.org/10.2147/CE.S50474

Ejemplares similares